Financial News to present the COVID-19 test products of Zhongjian Antai for you!

On the evening of May 2, 2021, Beijing Finance Channel's "Beijing Through Train" column aired a report about Beijing Zhongjian Antai Diagnostic Technology Co., Ltd.

COVID-19 testing products

COVID-19 antibodies combined rapid test

On the approach of the epidemic in 2020, relying on the r&d capacity of the Colloidal Gold platform, the company developed the world's first novel Corona virus IgA/IgM/IgG Antibody combined rapid test(Colloidal Gold Method), which was CE certified by the German authorities and sold to South Korea. Turkey, Iraq, Iran, Indonesia, Pakistan, the Philippines, Germany and more.

SARS-CoV-2 antigen rapid test

In 2021, many countries in the international community are still in the shadow of COVID-19, in order to detect novel Coronavirus earlier and more conveniently. Aetna has completed the development of the novel Coronavirus (SARS-COV-2) Antigen test kit (colloidal gold method), which can issue test results in 15 to 20 minutes via nasopharyngeal or oropharyngeal swab samples.

 COVID-19 neutralizing antibody Detection 

At present, vaccination against COVID-19 has become an important means for the international community to stop the spread of the epidemic. The Novel Coronavirus Neutralizing Antibody Test kit (Colloidal gold method) developed by Zhongjian Antai uses the principle of competition method to scientifically define the reagent threshold for the neutralizing test of the standardized COVID-19 pseudovirus and reflect the neutralizing antibody test results accurately and objectively. To provide a reference for evaluation of immunity effect after vaccination.

With more than 10 years of experience in the research and development of colloidal gold diagnostic technology, Zhongjian Antai is developing diagnostic products suitable for the global epidemic containment war. With the aim of providing advanced diagnostic technologies and excellent diagnostic products for public health, China's in-vitro diagnostic enterprises will play their due role in the protracted battle against COVID-19.